Cargando…

Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis

BACKGROUND: Evidence to guide type 2 diabetes treatment individualization is limited. We evaluated heterogeneous treatment effects (HTE) of intensive glycemic control in type 2 diabetes patients on major adverse cardiovascular events (MACE) in the Action to Control Cardiovascular Risk in Diabetes St...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edward, Justin A., Josey, Kevin, Bahn, Gideon, Caplan, Liron, Reusch, Jane E. B., Reaven, Peter, Ghosh, Debashis, Raghavan, Sridharan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047276/ https://www.ncbi.nlm.nih.gov/pubmed/35477454 http://dx.doi.org/10.1186/s12933-022-01496-7

Ejemplares similares

Progression of Vascular Calcification Is Increased With Statin Use in the Veterans Affairs Diabetes Trial (VADT)
por: Saremi, Aramesh, et al.
Publicado: (2012)

Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT)
por: Agrawal, Lily, et al.
Publicado: (2019)

The Effect of Intensive Glucose Lowering on Lipoprotein Particle Profiles and Inflammatory Markers in the Veterans Affairs Diabetes Trial (VADT)
por: Koska, Juraj, et al.
Publicado: (2013)

Association of PAI-1 and Fibrinogen With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT)
por: Azad, Nasrin, et al.
Publicado: (2014)

Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)
por: Koska, Juraj, et al.
Publicado: (2021)

Rates and Determinants of Coronary and Abdominal Aortic Artery Calcium Progression in the Veterans Affairs Diabetes Trial (VADT)
por: Saremi, Aramesh, et al.
Publicado: (2010)

Investigation of allele specific expression in various tissues of broiler chickens using the detection tool VADT
por: Tomlinson, M. Joseph, et al.
Publicado: (2021)

Oral diabetes medication monotherapy and short-term mortality in individuals with type 2 diabetes and coronary artery disease
por: Raghavan, Sridharan, et al.
Publicado: (2018)

Heterogeneous treatment effects of intensive glycemic control on kidney microvascular outcomes in ACCORD
por: Charu, Vivek, et al.
Publicado: (2023)

Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
por: Basu, Sanjay, et al.
Publicado: (2018)

Deterioration of Sleep Quality According to Glycemic Status
por: Hur, Myung Haeng, et al.
Publicado: (2020)

Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
por: Pei, Junyu, et al.
Publicado: (2023)

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
por: Saremi, Aramesh, et al.
Publicado: (2017)

Severe hypoglycemia predicts major adverse outcomes in diabetic patients undergoing glycemic control regimes
por: Kwok, Ching‐Fai, et al.
Publicado: (2011)

Meta-analysis based on weighted ordered P-values for genomic data with heterogeneity
por: Li, Yihan, et al.
Publicado: (2014)

Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events
por: Gu, Sophie Z, et al.
Publicado: (2023)

Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction
por: Adamek, Kylie E., et al.
Publicado: (2019)

Device-measured physical activity data for classification of patients with ventricular arrhythmia events: A pilot investigation
por: Marzec, Lucas, et al.
Publicado: (2018)

SMASH: Scalable Method for Analyzing Spatial Heterogeneity of genes in spatial transcriptomics data
por: Seal, Souvik, et al.
Publicado: (2023)

SMASH: Scalable Method for Analyzing Spatial Heterogeneity of genes in spatial transcriptomics data
por: Seal, Souvik, et al.
Publicado: (2023)

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2018)

Intensive Glycemic Control Is Not Associated With Fractures or Falls in the ACCORD Randomized Trial
por: Schwartz, Ann V., et al.
Publicado: (2012)

Effect on Glycemic, Blood Pressure, and Lipid Control according to Education Types
por: Choi, Mi-Ju, et al.
Publicado: (2011)

Point: Intensive Glycemic Control and Mortality in ACCORD—A Chance Finding?
por: Lachin, John M.
Publicado: (2010)

Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction
por: Su, Gong, et al.
Publicado: (2013)

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes
por: Hsu, Jung‐Chi, et al.
Publicado: (2023)

Glycemic variability: adverse clinical outcomes and how to improve it?
por: Zhou, Zheng, et al.
Publicado: (2020)

Regression hidden Markov modeling reveals heterogeneous gene expression regulation: a case study in mouse embryonic stem cells
por: Lee, Yeonok, et al.
Publicado: (2014)

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
por: Skyler, Jay S., et al.
Publicado: (2009)

The heterogeneous associations between gestational weight gain and adverse pregnancy outcomes in gestational diabetes mellitus according to abnormal glucose metabolism
por: Wu, Qi, et al.
Publicado: (2023)

Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort Study
por: Reaven, Nancy L., et al.
Publicado: (2023)

Effect of Intensive Glycemic and Blood Pressure Control on QT Prolongation in Diabetes: The ACCORD Trial
por: Singleton, Matthew J., et al.
Publicado: (2020)

Adversity and cooperation in heterogeneous pairs
por: De Jaegher, Kris
Publicado: (2019)

IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19
por: Ruge, M., et al.
Publicado: (2022)

Neuroanatomical Heterogeneity of Essential Tremor According to Propranolol Response
por: Chung, Seok Jong, et al.
Publicado: (2013)

Comparison of Improving Effects for Diabetic Erectile Dysfunction according to the Anti-Glycemic Agents: Phlorizin and Insulin
por: Park, Juhyun, et al.
Publicado: (2019)

Differences in Abdominal Body Composition According to Glycemic Status: An Inverse Probability Treatment Weighting Analysis
por: Han, Seungbong, et al.
Publicado: (2021)

Glucose concentrations after insulin‐induced hypoglycemia and glycemic variability in healthy and diabetic cats
por: Zini, Eric, et al.
Publicado: (2018)

Zinc and Glycemic Control
por: Dharmalingam, Mala, et al.
Publicado: (2019)

A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank
por: Kim, Do Hyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bpggomcgij6dqqp9orv1jgj2ra